Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christiane Querfeld

Showing results (111-120 of 136) with videos related to

Pageof 14
Sort By:
Journal of the American Academy of Dermatology|January 9, 2018
Progression of undiagnosed cutaneous lymphoma after anti-tumor necrosis factor-alpha therapyMaria Estela Martinez-Escala, Alba L Posligua, Heather Wickless, et al.
The Journal of Investigative Dermatology|November 14, 2021
MicroRNA Regulation of T-Cell Exhaustion in Cutaneous T Cell LymphomaZhen Han, Renee J Estephan, Xiwei Wu, et al.
Blood Advances|February 14, 2025
Phase 1 trial of durvalumab (anti-PD-L1) combined with lenalidomide in relapsed/refractory cutaneous T-cell lymphomaChristiane Querfeld, Joycelynne Palmer, Zhen Han, et al.
Leukemia & Lymphoma|June 9, 2011
Multicenter phase II trial of enzastaurin in patients with relapsed or refractory advanced cutaneous T-cell lymphomaChristiane Querfeld, Timothy M Kuzel, Youn H Kim, et al.
International Journal of Laboratory Hematology|June 7, 2023
Profiling endogenous, environmental, and infectious disease mutational signatures in blastic plasmacytoid dendritic cell neoplasmsCorinn Small, Soham Mukerjee, Diwash Jangam, et al.
The Journal of Investigative Dermatology|May 15, 2018
Multi-Kinase Inhibitor with Anti-p38γ Activity in Cutaneous T-Cell LymphomaXu Hannah Zhang, Sangkil Nam, Jun Wu, et al.
The Lancet. Haematology|October 10, 2021
Intralesional TTI-621, a novel biologic targeting the innate immune checkpoint CD47, in patients with relapsed or refractory mycosis fungoides or Sézary syndrome: a multicentre, phase 1 studyChristiane Querfeld, John A Thompson, Matthew H Taylor, et al.
Cancer Immunology Research|June 14, 2018
Primary T Cells from Cutaneous T-cell Lymphoma Skin Explants Display an Exhausted Immune Checkpoint ProfileChristiane Querfeld, Samantha Leung, Patricia L Myskowski, et al.
Blood Cancer Journal|November 10, 2020
Targeted genomic analysis of cutaneous T cell lymphomas identifies a subset with aggressive clinicopathological featuresKimon V Argyropoulos, Melissa Pulitzer, Francesco Maura, et al.
Blood Advances|April 10, 2019
Targeting CD47 in Sézary syndrome with SIRPαFcLisa D S Johnson, Swati Banerjee, Oleg Kruglov, et al.
Pageof 14

Showing results (111-120 of 136) with videos related to

Sort By:
Pageof 14
Journal of the American Academy of Dermatology|January 9, 2018
Progression of undiagnosed cutaneous lymphoma after anti-tumor necrosis factor-alpha therapyMaria Estela Martinez-Escala, Alba L Posligua, Heather Wickless, et al.
The Journal of Investigative Dermatology|November 14, 2021
MicroRNA Regulation of T-Cell Exhaustion in Cutaneous T Cell LymphomaZhen Han, Renee J Estephan, Xiwei Wu, et al.
Blood Advances|February 14, 2025
Phase 1 trial of durvalumab (anti-PD-L1) combined with lenalidomide in relapsed/refractory cutaneous T-cell lymphomaChristiane Querfeld, Joycelynne Palmer, Zhen Han, et al.
Leukemia & Lymphoma|June 9, 2011
Multicenter phase II trial of enzastaurin in patients with relapsed or refractory advanced cutaneous T-cell lymphomaChristiane Querfeld, Timothy M Kuzel, Youn H Kim, et al.
International Journal of Laboratory Hematology|June 7, 2023
Profiling endogenous, environmental, and infectious disease mutational signatures in blastic plasmacytoid dendritic cell neoplasmsCorinn Small, Soham Mukerjee, Diwash Jangam, et al.
The Journal of Investigative Dermatology|May 15, 2018
Multi-Kinase Inhibitor with Anti-p38γ Activity in Cutaneous T-Cell LymphomaXu Hannah Zhang, Sangkil Nam, Jun Wu, et al.
The Lancet. Haematology|October 10, 2021
Intralesional TTI-621, a novel biologic targeting the innate immune checkpoint CD47, in patients with relapsed or refractory mycosis fungoides or Sézary syndrome: a multicentre, phase 1 studyChristiane Querfeld, John A Thompson, Matthew H Taylor, et al.
Cancer Immunology Research|June 14, 2018
Primary T Cells from Cutaneous T-cell Lymphoma Skin Explants Display an Exhausted Immune Checkpoint ProfileChristiane Querfeld, Samantha Leung, Patricia L Myskowski, et al.
Blood Cancer Journal|November 10, 2020
Targeted genomic analysis of cutaneous T cell lymphomas identifies a subset with aggressive clinicopathological featuresKimon V Argyropoulos, Melissa Pulitzer, Francesco Maura, et al.
Blood Advances|April 10, 2019
Targeting CD47 in Sézary syndrome with SIRPαFcLisa D S Johnson, Swati Banerjee, Oleg Kruglov, et al.
Pageof 14